Mgo One Seven LLC Novartis Ag Transaction History

Mgo One Seven LLC

$4.05 Billion
Q3 2025

A detailed history of Mgo One Seven LLC transactions in Novartis Ag stock. As of the latest transaction made, Mgo One Seven LLC holds 26,315 shares of NVS stock, worth $3.26 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

26,315

Previous 23,951 9.87%

Holding current value

$3.26 Million

Previous $2.9 Million 16.43%

% of portfolio

0.08%

Previous 0.1%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	BUY	$113.5 - $129.73 $268,314 - $306,681	2,364 Added 9.87%	26,315 $3.37 Million
Q2 2025 Jul 25, 2025	BUY	$101.96 - $121.01 $65,662 - $77,930	644 Added 2.76%	23,951 $2.9 Million
Q1 2025 May 08, 2025	SELL	$97.14 - $115.57 $427,707 - $508,854	-4,403 Reduced 15.89%	23,307 $2.6 Million
Q4 2024 Feb 14, 2025	BUY	$96.78 - $117.18 $294,404 - $356,461	3,042 Added 12.33%	27,710 $2.7 Million
Q3 2024 Oct 15, 2024	SELL	$106.13 - $120.89 $188,805 - $215,063	-1,779 Reduced 6.73%	24,668 $2.84 Million
Q2 2024 Aug 07, 2024	SELL	$92.57 - $107.37 $58,319 - $67,643	-630 Reduced 2.33%	26,447 $2.82 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $656,315 - $747,249	-6,889 Reduced 20.28%	27,077 $2.62 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $189,522 - $208,563	2,054 Added 6.44%	33,966 $3.43 Million
Q3 2023 Nov 03, 2023	SELL	$94.73 - $105.13 $95,203 - $105,655	-1,005 Reduced 3.05%	31,912 $3.25 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $120,368 - $136,487	-1,301 Reduced 3.8%	32,917 $3.32 Million
Q1 2023 May 08, 2023	BUY	$80.03 - $92.81 $101,077 - $117,219	1,263 Added 3.83%	34,218 $3.15 Million
Q4 2022 Jan 25, 2023	BUY	$75.55 - $92.52 $148,455 - $181,801	1,965 Added 6.34%	32,955 $0
Q3 2022 Nov 14, 2022	BUY	$74.61 - $87.26 $232,633 - $272,076	3,118 Added 11.19%	30,990 $4.03 Million
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $377,316 - $439,312	-4,686 Reduced 14.39%	27,872 $2.36 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $29,800 - $33,710	-372 Reduced 1.13%	32,558 $2.45 Million
Q4 2021 Feb 09, 2022	SELL	$79.7 - $88.13 $90,300 - $99,851	-1,133 Reduced 3.33%	32,930 $2.48 Million
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $16,437 - $19,123	-201 Reduced 0.59%	34,063 $2.44 Million
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $5,029 - $5,554	-59 Reduced 0.17%	34,264 $2.7 Million
Q1 2021 Apr 29, 2021	SELL	$83.5 - $98.47 $612,723 - $722,572	-7,338 Reduced 17.61%	34,323 $2.54 Million
Q4 2020 Jan 22, 2021	SELL	$78.07 - $94.43 $94,386 - $114,165	-1,209 Reduced 2.82%	41,661 $3.5 Million
Q3 2020 Oct 30, 2020	SELL	$82.14 - $91.0 $236,973 - $262,535	-2,885 Reduced 6.31%	42,870 $3.33 Million
Q2 2020 Aug 12, 2020	BUY	$80.93 - $91.1 $395,100 - $444,750	4,882 Added 11.94%	45,755 $3.59 Million
Q1 2020 Apr 17, 2020	BUY	$70.67 - $99.01 $17,950 - $25,148	254 Added 0.63%	40,873 $3.37 Million
Q4 2019 Jan 16, 2020	BUY	$84.35 - $95.37 $181,689 - $205,426	2,154 Added 5.6%	40,619 $3.85 Million
Q3 2019 Oct 10, 2019	BUY	$85.54 - $94.26 $239,768 - $264,210	2,803 Added 7.86%	38,465 $3.34 Million
Q2 2019 Jul 16, 2019	BUY	$75.4 - $92.8 $537,149 - $661,107	7,124 Added 24.96%	35,662 $3.26 Million
Q1 2019 Apr 09, 2019	BUY	$75.32 - $86.15 $1.07 Million - $1.22 Million	14,161 Added 98.5%	28,538 $2.74 Million
Q4 2018 Jan 24, 2019	BUY	$73.66 - $82.02 $87,360 - $97,275	1,186 Added 8.99%	14,377 $1.23 Million
Q3 2018 Oct 09, 2018	BUY	$66.94 - $77.43 $37,486 - $43,360	560 Added 4.43%	13,191 $1.14 Million
Q1 2018 May 15, 2018	SELL	$70.39 - $84.15 $64,758 - $77,418	-920 Reduced 6.79%	12,631 $1.02 Million
Q4 2017 Feb 16, 2018	BUY	$72.33 - $77.64 $980,143 - $1.05 Million	13,551	13,551 $1.14 Million

Others Institutions Holding NVS

# of Institutions

1,582

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $266B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.

Account